EUCTR2013-002878-47-ES进行中（未招募）不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensification - DUAL? - Intensification
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Completion (Visit 28) of NN9068-3952 with insulin degludec/liraglutide + metformin.
- •2. HbA1c ? 7% at Visit 27 of NN9068-3952 trial.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 51
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 13
排除标准
- •1. Clinically significant diseases of the major organ systems.
- •2. Screening calcitonin ? 50ng/L.
研究者
相似试验
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2EUCTR2013-002878-47-HUovo Nordisk A/S64
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2EUCTR2013-002878-47-SKovo Nordisk A/S64
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2013-002878-47-GRovo Nordisk A/S64
已完成
不适用
Evaluating the effect of a new supplement on recovery after open heart surgeryIRCT201312102480N3Shiraz University of Medical Sciences92
招募中
不适用
Blood sugar control after bypass operation - insulin vs oral medicatioheart disease, diabetesSLCTR/2014/024ational Hospital of Sri Lanka330